FDA Approves Moderna's mRNA Flu Vaccine for Adults 50 and Older

The FDA approved Moderna's mRNA flu vaccine for adults aged 50 and older across the United States. This is the first licensed flu shot to use mRNA technology. The approval is standard for ages 50 to 64 but accelerated for those 65 and older. That accelerated approval requires a post-marketing trial to confirm the benefit.

CHECKED · 1 SOURCE · UNCORROBORATED ✓